Anzeige
Mehr »
Samstag, 30.08.2025 - Börsentäglich über 12.000 News
SuperBuzz: Die KI-Aktie, die man sich jetzt zum Ende des Sommers nicht entgehen lassen darf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
258 Leser
Artikel bewerten:
(1)

Nitches, Inc.: InTheZone Labs, a Wholly Owned Subsidiary of Nitches Inc. , Enters 2025 With a Blooming Affiliate Network and Bold Expansion Plans

MIAMI, FLORIDA / ACCESS Newswire / February 18, 2025 / Nitches, Inc (OTC PINK:NICH) - In a dynamic move that's turning heads in the $6.3 trillion global wellness industry, InTheZone Labs-a wholly owned subsidiary of Nitches Inc. (OTC:$NICH)-today announced substantial growth across its TikTok affiliate program. Following a surge of over 80 new TikTok Shop affiliates (with more on the horizon via ShareASale and Awin), the company is poised to revolutionize how consumers discover high-quality nootropics, supplements, and de-aging solutions.

"We're witnessing a tidal wave of awareness and sales driven by short, authentic videos and TikTok Lives," said a company spokesperson. "The network effect of affiliates sharing real-life testimonials has already translated into thousands of views-and a robust, rapidly scaling sales pipeline."

After Valentine's Day Flash Sale on TikTok

To reward the influx of new customers exploring these breakthrough nootropics, InTheZone Labs is launching a limited-time 50% discount on its product line exclusively through the TikTok Shop. While the main website (InTheZoneLabs.com) and Amazon store are holding at standard pricing, the company sees this exclusive sale as a strategic way to build brand evangelists through the viral power of TikTok.

Amplifying on X and Beyond

Curated highlights and customer stories are now making their way onto X (formerly Twitter), creating an omnichannel marketing wave. As more affiliates join from leading networks like ShareASale, the content will ripple across Instagram, YouTube, and multiple other social platforms.

Why Nootropics Are on the Rise

Nootropic supplements and de-aging solutions are fast emerging as the new frontier of wellness. Ingredients such as lion's mane mushrooms, L-theanine, alpha-GPC, and phosphatidylserine have garnered widespread acclaim for supporting mental clarity, sustained energy, and overall cognitive function. With a forecasted upswing in the global supplement market, InTheZone Labs is uniquely positioned to educate consumers on these benefits-while tapping into an immense, underserved audience.

Key Partnership Opportunities
1. TikTok Shop Affiliates - Perfect for creators who thrive on short, high-impact videos, looking to turn viral moments into long-term revenue.
2. Amazon Shop Affiliates - Ideal for influencers capitalizing on Amazon's colossal reach and nootropic category dominance.
3. Distributors & Big-Box Retail - InTheZone Labs® is already laying the groundwork for major retail partnerships, ensuring top-tier cognitive-support supplements are accessible to a global consumer base.

Looking to the Future

As the line between wellness and technology continues to blur, InTheZone Labs sees enormous potential in harnessing social commerce platforms. "All it takes is one viral video to spark a massive wave of sales and brand loyalty," added the spokesperson. "Whether you're on TikTok, Amazon, or looking to distribute in big-box stores, this is the moment to jump in.**"

Contact Us for Affiliate or Distributor Info

Interested parties are encouraged to explore partnership details at:
https://inthezonelabs.com/distribution-affiliates/
or contact the company directly to discuss commission structures, marketing assets, and collaborative strategies.

Forward-Looking Statements & FDA Disclaimer

Certain statements in this press release constitute "forward-looking statements" within the meaning of federal securities laws. These statements are based on current expectations, estimates, and projections regarding the business of Nitches Inc. and InTheZone Labs, which speak only as of the date hereof. Actual results or developments may differ materially from those projected.

These products and statements have not been evaluated by the Food and Drug Administration (FDA). They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Always consult a healthcare professional before beginning any supplementation program.

Contact Information

John Morgan
Ceo
info@nitchescorp.com

SOURCE: Nitches, Inc.



© 2025 ACCESS Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.